Fierce Pharma Biopharma News & Insights
Dec 19, 2024 · Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader pharma industry, including manufacturing, marketing and finance.
Pharma | Fierce Pharma
Oct 14, 2024 · BMS has reported that two phase 3 trials of Sotyktu in psoriatic arthritis have achieved their primary endpoints.
Editor's Corner: The top 10 Fierce Pharma Marketing stories of …
4 days ago · Number three is a “naughty pharma” story. This time, it was two naughty pharmas in AstraZeneca and GSK who were both separately chided by the U.K.’s drug marketing watchdog, the PMCPA, for ...
Novo Nordisk wins hard-fought FDA approval for once-daily …
3 days ago · Digging deeper into the data, the estimated average ABR for patients on Novo’s drug was 1.7 versus 11.8 for patients with no prophylaxis, while the respective median ABR was zero for treated ...
Recapping Fierce Pharma's top stories of the year
4 days ago · With top stories No. 4 and No. 6 of the year, you’ll again see the reader's enthusiasm for GLP-1 drug launches. Both pieces focused on the overwhelming demand for the booming diabetes drugs from ...
Fierce 50 of 2024 | Fierce Pharma
Sep 9, 2024 · I’m honored to introduce the second edition of the Fierce 50, where we once again spotlight the innovators and leaders driving the future of healthcare, pharma and biotech. This year’s ...
'The Top Line': A look at pharma revenue rankings
Apr 26, 2024 · Fierce Pharma publishes a yearly special report highlighting the top 20 pharmas based on their revenue. The most recent edition, published this month, ranks each pharma based on their total ...
Fierce Biotech News & Reports - Fierce Pharma
Apr 15, 2024 · Shining a spotlight on the people and companies who are driving meaningful change in healthcare, pharma and biotech.
Fierce Pharma Week | Fierce Pharma
Fierce Pharma Week will bring together life science executives responsible for marketing and sales, medical affairs and scientific communications, new product planning and commercial development ...
Editor's corner: Fierce Pharma's top 10 stories of 2022
Dec 22, 2022 · Another pair of top stories in 2022 captured an ongoing trend for the industry—reorganizations and layoffs. In April, Novartis revealed a major restructuring aimed at cutting $1 billion in ...